In summary, our findings provide mechanistic insights into HJURP/PRDX1-mediated antioxidant defense and highlight the potential of HJURP/PRDX1 as novel diagnostic and therapeutic targets for ferroptosis-based treatment in PCa patients. The gene discussed is HJURP; the disease is posterior cortical atrophy.